Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
theres some very good article on advfn thread, each day goes by and this gets more expensive to buy, come on results day some will regret not buying now, rcg gives divident, beats market expectation every time!! growing fast, products are the future
i have decided to invest all my money into this, results in 4 weeks time, im very sure buying into this price will return a 25 to 50 % gain imho
rcgs biometrix exhibition in months or so time this share represents a bargain, do not listen to papalpower on this and nina wangs should be drawing to close
annoucement of forestry permit anytime now, if that happens these will sky rocket
http://www.mcvuk.com/news/31358/SCi-banks-on-best-ever-Tomb-Raider
lots of games being released, tomb raider will earn alot of money for this com, apparently tr underworld is the best ever!
jb selling i think is almost finish, great time to get in, soon they will produce 100000 bopd
OPG Power Ventures - Profitable Indian energy group 70p Epic code: OPG (Sharewatch) There is no doubt that investors are feeling nervous about the UK economy and its growth prospects. But one country still in the midst of a strong growth path is India and as the country's economy expands, so do its requirements for infrastructure including power, telecoms, roads and ports. Against that backcloth, one exciting new issue this month is OPG Power Ventures, which owns and manages power generation plants in India. The deregulation of the sector over the past few years has meant private companies can supply industrial customers with their electricity with little interference from the state on the price they charge. This is encouraging OPG to step up expansion and although the company presently operates just one power plant in India, it has three in the pipeline. Not only is there a quantum leap in the size of the new plants being developed but there has been a rule change that means OPG will be able to own a higher percentage of these hugely profitable future plants itself rather than having to take on minority investors. Broker Cenkos is already forecasting an explosive period of growth with sales rising more than ten-fold in the next two years from US$12.1m being forecast for the year ended on 31 March to US$130m in 2010. Profit before tax is expected to do the same, lifting from US$6m to US$61.6m. India is short on power OPG clearly has the makings of a strong g
Eaga 108.5p Epic code: EAGA (Sharewatch) Eaga has announced that it has entered into framework agreements with all six major utilities in the UK as part of the delivery of their obligations under the Carbon Emissions Reduction Target (CERT). CERT places obligations on utility companies to fund domestic energy efficiency measures (which Eaga installs on their behalf) and spending over the next three years is expected to be £2.8 billion - double that of the previous scheme. Citi forecasts eps of 10.4p for the year ended on 31 May with 12.8p for the current year, to drop the PE to 7.7. Its share price target is 160p. Hold. * The writer has a holding
All UK energy suppliers have to meet Carbon Emissions Reduction Target (CERT) obligation. we are likely to see more contracts from other utilities firm
good news see advfn
trading update next week
has secured £1.5billion warm front contract from government
can u post the article please, thanks
check advfn
So , its now looking pretty cheap due to: 1....Results next Thur. 2....Cash of around £82m (42p) compared to todays sp of 25.5p. 3....Very likely bid by Shire imho as it makes far more sense to buy-out RNVO at these prices rather than pay the "milestones worth $825m". 4....JP Morgan target of 100p 5....HB "spec buy" on 04 Mar 08 6....Cannacord 79p target 7..
At 25.5p, the current Mkt Cap is around £50m, but they will still have cash of around £82m when they announce their results next thursday (29th May). This cash is worth 42p leaving them trading at a significant discount to cash. Considering they still have 4 products in trials this makes them an absolute bargain. Considering the reason for the fall was the recent failed "breast" trial which used SINGLE daily dosing, instead of the usual DOUBLE daily dosing which has been successfully used in 7 out of 9 Juvista trials so far, then this seems perhaps a little unfair. Even JP Morgan commented on this saying "The fall in Renovo’s share price following this news appears unjustified". In addition to this, a note by Cannacord went on to say that even "with Juvista missing an endpoint in a trial".....Juvista’s commercial potential is significant." and went on to give them a target of 79p. Even the Hoodless note pointed out (at 60p at the beginning of Mar 08)that "Shire could view a buyout as offering better value alternative to sticking with the licensing deal terms requiring payments of circa $825m." . So , its now looking pretty cheap due to: 1....Results next Thur. 2....Cash of around £82m (42p) compared to todays sp of 25.5p. 3....Very likely bid by Shire imho as it makes far more sense to buy-out RNVO at these prices rather than pay the "milestones worth $825m". 4....JP Morgan
check advfn comments and goodluck
have u had a look at this, currently its trading below its net cash value? what do u think, i just bought some